Your browser doesn't support javascript.
COVID-19 in pregnant women after assisted reproductive technologies receiving low molecular weight heparins
Obstetrics, Gynecology and Reproduction ; 15(3):225-227, 2021.
Article in Russian | EMBASE | ID: covidwho-1344587
ABSTRACT
We have accumulated my own experience of management pregnant women with COVID-19 after assisted reproductive technologies (ART) receiving low molecular weight heparins (LMWH). All women suffered COVID-19 in mild form without respiratory failure and gave birth to healthy children. Our observations correspond to the data of world literature. Therefore, we want to draw the attention of the editors and the readers to the positive role of LMWH in the control of COVID-19.

Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Observational study / Prognostic study Language: Russian Journal: Obstetrics, Gynecology and Reproduction Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: Databases of international organizations Database: EMBASE Type of study: Observational study / Prognostic study Language: Russian Journal: Obstetrics, Gynecology and Reproduction Year: 2021 Document Type: Article